Clinical Trials Directory

Trials / Completed

CompletedNCT04165369

Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury

Status
Completed
Phase
Study type
Observational
Enrollment
10,568 (actual)
Sponsor
University Hospital Muenster · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit.

Detailed description

Acute kidney injury (AKI) is a severe clinical complication with increasing incidence and is associated with adverse short- and long-term outcomes resulting in a major health care burden worldwide. The introduction of consensus classification systems has enhanced the awareness for AKI. The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. However, analyzing AKI from existing databases is often limited by missing data elements, especially the inclusion of the urine output criteria. Missing data and the use of different definitions before the consensus classification are the reasons for large variations in reported occurrences of surgical induced AKI. The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit (e.g., Intensive Care Unit, Intermediate Care, Post Anesthesia Care Unit) using the latest consensus definition for AKI (Kidney Disease: Improving Global Outcomes criteria) and a standardized data collection instrument and to assess the dependence of AKI on preoperative and intraoperative factors. Method: International prospective, observational, multi-center, cross-sectional cohort study Eligible patients will be identified during preoperative assessment. All eligible patients will be approached to obtain written consent.

Conditions

Timeline

Start date
2020-06-09
Primary completion
2022-02-28
Completion
2022-03-31
First posted
2019-11-18
Last updated
2022-07-21

Locations

82 sites across 14 countries: United States, Egypt, France, Germany, Italy, Libya, Malta, North Macedonia, Palestinian Territories, Russia, Saudi Arabia, Slovenia, Spain, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04165369. Inclusion in this directory is not an endorsement.